The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab (Nivo) vs investigator’s choice (IC) for platinum-refractory (PR) recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN; Checkmate 141): Outcomes in first-line (1L) R/m patients and updated safety and efficacy.
 
Maura L. Gillison
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Lilly; Merck
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Lilly; Merck
Research Funding - AstraZeneca; Bristol-Myers Squibb; Kyowa Hakko Kirin; Merck
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Lilly; Merck
 
George R. Blumenschein
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Merck
Research Funding - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Merck; Novartis; Xcovery
 
Jérôme Fayette
Leadership - Glycotope GmbH
Honoraria - AstraZeneca; Bristol-Myers Squibb
 
Joel Guigay
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MERCK SERONO (Inst)
 
A. Dimitrios Colevas
Stock and Other Ownership Interests - Gilead Sciences; Pharmacyclics
Research Funding - Bristol-Myers Squibb; Curis; Genentech
 
Lisa Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Eisai; Merck Serono; MSD; Novartis; Roche; SOBI
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Debiopharm Group; Merck Serono; SOBI
 
Kevin Harrington
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pfizer
Research Funding - MSD
 
Stefan Kasper
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Everett E. Vokes
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; Leidos Biomedical Research; Lilly; Merck; Merck Serono; Regeneron; Takeda; VentiRx
 
Caroline Even
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Innate Pharma; Merck Serono; MSD
 
Francis P. Worden
Honoraria - Bayer
Consulting or Advisory Role - Bristol-Myers Squibb; Genzyme; Merck
 
Nabil F. Saba
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer
 
Lara Carmen Iglesias Docampo
Consulting or Advisory Role - Bayer; Genzyme
Speakers' Bureau - Eisai; Takeda
Expert Testimony - Bristol-Myers Squibb; Kyowa Hakko Kirin
 
Robert I. Haddad
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst); VentiRx (Inst)
 
Tamara Rordorf
Travel, Accommodations, Expenses - MSD
 
Naomi Kiyota
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Ono Pharmaceutical
Research Funding - AstraZeneca; Boehringer Ingelheim; Ono Pharmaceutical
 
Makoto Tahara
Honoraria - Bayer; Bristol-Myers Squibb; Eisai; Merck Serono; Takeda
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Ono Pharmaceutical; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); NanoCarrier (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Mark John Lynch
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Justin Kopit
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Robert L. Ferris
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; Merck; Pfizer
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; VentiRx